Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urinary 3-hydroxyproline in renal disease

J Chanard, A Szymanowicz, J P Brunois

    Renal Physiology
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Interest of reTURB for pTa high grade bladder urothelial carcinoma].

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2019
    Same author

    Uterus-like mass: A case report.

    European journal of obstetrics, gynecology, and reproductive biology·2018
    Same author

    Papillary endothelial hyperplasia (Masson's tumor) in children.

    Annales de chirurgie plastique et esthetique·2016
    Same author

    Contribution of Raman spectroscopy in nephrology: a candidate technique to detect hydroxyethyl starch of third generation in osmotic renal lesions.

    The Analyst·2015
    Same author

    Three-year outcomes in kidney transplant patients randomized to steroid-free immunosuppression or steroid withdrawal, with enteric-coated mycophenolate sodium and cyclosporine: the infinity study.

    Journal of transplantation·2014
    Same author

    [Regeneration of airway epithelium].

    Revue des maladies respiratoires·2014

    Urinary 3-hydroxyproline (3-HYP) levels are elevated in acute kidney diseases like glomerulonephritis and polycystic kidney disease (PKD). This suggests 3-HYP may indicate specific kidney conditions and potential collagen metabolism errors in PKD.

    Area of Science:

    • Nephrology
    • Biochemistry
    • Collagen Metabolism

    Background:

    • 3-hydroxyproline (3-HYP) is a collagen isomer more abundant in basement membranes than interstitial collagen.
    • Urinary 3-HYP and 4-HYP excretion patterns can reflect kidney health and collagen turnover.
    • Investigating 3-HYP in kidney disease may reveal diagnostic markers.

    Purpose of the Study:

    • To investigate renal excretion of 3-hydroxyproline (3-HYP) in various kidney diseases.
    • To compare 3-HYP levels and ratios with 4-hydroxyproline (4-HYP) in control and patient groups.
    • To identify potential correlations between urinary 3-HYP and specific nephropathies.

    Main Methods:

    • Analysis of urinary 3-hydroxyproline (3-HYP) and 4-hydroxyproline (4-HYP) in 58 adult patients with kidney diseases and healthy controls.

    Related Experiment Videos

  • Renal biopsy used for diagnosing most nephropathies, excluding polycystic renal disease (PKD).
  • Calculation of the 3-HYP/4-HYP ratio to assess collagen metabolism alterations.

    • Main Results:

    • In healthy adults, the urinary 3-HYP/4-HYP ratio was 5.5 ± 0.5.
    • Patients with acute/subacute glomerulonephritis showed an increased 3-HYP/4-HYP ratio (7.3 ± 0.7).
    • Chronic glomerulonephritis and diabetic glomerulonephritis did not show increased 3-HYP; chronic interstitial nephritis showed a decreased ratio, except in PKD where it was elevated.

    Conclusions:

    • Elevated urinary 3-HYP is associated with acute or subacute glomerulonephritis.
    • Increased 3-HYP/4-HYP ratio in polycystic kidney disease (PKD) suggests a potential inborn error of collagen metabolism.
    • Urinary 3-HYP may serve as a biomarker for specific kidney conditions.